Leerink Partners Assumes Contineum Therapeutics (CTNM) at Outperform
Tweet
Share
E-mailGet Alerts CTNM Hot Sheet
Price: $14.62 --0%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 19 | New: 5
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 19 | New: 5
Join SI Premium – FREE
Leerink Partners analyst Roanna Ruiz assumes coverage on Contineum Therapeutics (NASDAQ: CTNM) with a Outperform rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Contineum Therapeutics click here. For more ratings news on Contineum Therapeutics click here.
Shares of Contineum Therapeutics closed at $11.47 yesterday.
You May Also Be Interested In
- Jefferies Starts Busy Ming Group (1768:HK) at Buy
- BofA Securities Starts Bel Fuse (BELFB) at Buy
- BofA Securities Downgrades Sylvamo Corp. (SLVM) to Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
